In order to test the antitumoral effect of the EphA2 inhibitor ALW-II-41-27, we generated patient-derived in vitro models, starting with six primary tumor tissues (OS-29, OS-26, ES-7, ES-15, CS-281, and CS-347). The gene discussed is EPHA2; the disease is neoplasm.